<DOC>
	<DOCNO>NCT00123383</DOCNO>
	<brief_summary>The study aim evaluate safety efficacy modafinil ( 200 mg/day ) 10 week plus tailored cognitive behavioural therapy program treatment cocaine dependence .</brief_summary>
	<brief_title>Randomised Placebo-Controlled Trial Modafinil Cocaine Dependence</brief_title>
	<detailed_description>Modafinil novel wake promote agent approve Australia treatment narcolepsy . Preliminary study suggest modafinil may value treatment psychostimulant dependence positive effect mood , sleep pattern , concentration , fatigue drug craving . It appear well tolerate low abuse liability . Thirty dependent cocaine user randomise 2 equal group . The experimental group receive modafinil 200 mg/day 10 week tailor cognitive behavioural therapy program . The control group receive placebo equivalent condition . Primary outcome group comparison cocaine negative urine sample collect 10 week study period . Adverse event , side effect , compliance , retention , self report health , psychosocial drug use outcome also compare group .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>DSMIV cocaine dependence diagnosis Cocaine positive urine sample intake Regular current cocaine use ( 23 day per week ) Aged 18 year old Pregnant nursing female Concurrent uncontrolled physical mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Modafinil</keyword>
	<keyword>Cocaine Dependence</keyword>
	<keyword>Randomised placebo-controlled trial</keyword>
</DOC>